Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A team of environmental biologists at the Chinese Research Academy of Environmental Sciences, working with one colleague from Duke University, and another from National University of Singapore, has ...

Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

Microbe-derived indoles modulate anxiety and neuronal excitability in the amygdala of germ-free (GF) male mice. These ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.

Novo's blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ...